[Combined chemoimmunotherapy in stomach cancer and hematosarcoma].
A new method was elaborated for the combined chemoimmunotherapy of cancer and hematosarcoma of the stomach by means of intratumoral submucous injection via a fiberoptic endoscope of 5-fluorouracil (or cyclophosphane) followed by general ftorafur chemotherapy (or vincristine, cyclophosphane, 5-fluorouracil) followed by general ftorafur chemotherapy (or vincristine, cyclophosphane, 5-fluorouracil), or by intratumoral submucous injection of zymosane at termination of the chemotherapy course. The material comprising 96 patients, treated by the new method and 52 control patients after general chemotherapy has proved a greater efficacy of the method of combined chemoimmunotherapy, especially in infiltrative-exophytic and perigastric recurrences of cancer of the stomach as well as in radically operated subjects.
D003520:Cyclophosphamide / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005472:Fluorouracil / Q000008:administration & dosage; D006394:Hemangiosarcoma / Q000401:mortality / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D009364:Neoplasm Recurrence, Local / Q000628:therapy; D013274:Stomach Neoplasms / Q000401:mortality / Q000628:therapy*; D005641:Tegafur / Q000008:administration & dosage; D013997:Time Factors
D005641:Tegafur; D003520:Cyclophosphamide; D005472:Fluorouracil
Kombinirovannaia khimioimmunoterapiia pri rake i gematosarkome zheludka.